Airsculpt Technologies, Inc.
AIRS- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001870940
In the last 90 days, Airsculpt Technologies, Inc. insiders filed 1 open-market purchase and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $205.1M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 11:01 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $11.7M (7.7% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 16, 2026 | Jan 13, 2025 | Feb 27, 2024 | Mar 10, 2023 | Mar 11, 2022 |
| Revenue | $151.8M | $180.3M | $195.9M | $168.8M | $133.3M |
| Selling, general and administrative | $82.2M | $98.9M | $102.4M | $101.4M | $65.7M |
| Operating income | -$11.6M | -$1.82M | $9.48M | -$4.54M | $15.8M |
| Interest expense | – | – | $6.49M | $6.75M | $4.89M |
| Income tax | -$5.97M | $188.0K | $7.48M | $3.38M | $329.0K |
| Net income | -$11.7M | -$8.25M | -$4.48M | -$14.7M | $10.6M |
| EPS, basic | $-0.19 | $-0.14 | $-0.08 | $-0.26 | $-0.01 |
| EPS, diluted | $-0.19 | $-0.14 | $-0.08 | $-0.26 | $-0.01 |
| Weighted shares, basic | 60.5M | 57.7M | 56.8M | 55.7M | 55.6M |
| Weighted shares, diluted | 60.5M | 57.7M | 56.8M | 55.7M | 55.6M |
| Margins and growth | |||||
| Operating margin | -7.6% | -1.0% | 4.8% | -2.7% | 11.8% |
| Net margin | -7.7% | -4.6% | -2.3% | -8.7% | 7.9% |
| Revenue growth, year over year | −15.8% | −7.9% | +16.1% | +26.6% | – |
| Net income growth, year over year | – | – | – | −239.1% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 16, 2026 | Jan 13, 2025 | Feb 27, 2024 | Mar 10, 2023 | Mar 11, 2022 |
| Cash and equivalents | $8.45M | $8.23M | $10.3M | $9.62M | $25.3M |
| Total current assets | $15.5M | $17.1M | $16.0M | $16.7M | $29.4M |
| Property, plant and equipment | $27.8M | $37.5M | $28.9M | $24.2M | $13.6M |
| Goodwill | $81.7M | $81.7M | $81.7M | $81.7M | $81.7M |
| Intangible assets | $36.8M | $41.6M | $46.3M | $51.1M | $55.9M |
| Total assets | $187.3M | $210.0M | $204.0M | $200.8M | $200.6M |
| Accounts payable | $5.37M | $6.26M | $3.92M | $3.84M | $2.67M |
| Short-term debt | $5.46M | $4.25M | $2.13M | $2.13M | $850.0K |
| Total current liabilities | $27.9M | $28.6M | $20.3M | $22.3M | $16.4M |
| Long-term debt | $50.6M | $65.5M | $69.5M | $81.4M | $81.8M |
| Total liabilities | $99.6M | $130.7M | $120.0M | $130.0M | $117.0M |
| Shareholders' equity | $87.7M | $79.3M | $84.0M | $70.8M | $83.5M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Reported | Mar 16, 2026 | Jan 13, 2025 | Feb 27, 2024 | Mar 10, 2023 | Mar 11, 2022 |
| Operating cash flow | $3.10M | $11.3M | $24.0M | $24.4M | $26.6M |
| Capital expenditures | $2.40M | $14.0M | $9.92M | $12.9M | $7.12M |
| Free cash flow | $692.0K | -$2.66M | $14.0M | $11.5M | $19.5M |
| Depreciation and amortization | $12.8M | $11.9M | $10.3M | $8.06M | $6.60M |
| Stock-based compensation | $2.33M | $3.76M | $18.2M | $29.5M | $7.18M |
| Dividends paid | $0 | $252.0K | $385.0K | $23.2M | – |
| Investing cash flow | -$2.40M | -$14.0M | -$9.92M | -$12.9M | -$7.12M |
| Financing cash flow | -$478.0K | $630.0K | -$13.4M | -$27.3M | -$4.55M |
| Net change in cash | $214.0K | -$2.03M | $646.0K | -$15.7M | $15.0M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.5% | 2.1% | 9.3% | 17.5% | 5.4% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 6, 2026 | 73.9M | +18.4% | SEC |
| Aug 7, 2026 | 72.1M | +15.5% | SEC |
| May 7, 2026 | 70.5M | +20.0% | SEC |
| Mar 30, 2026 | 70.5M | +20.4% | SEC |
| Nov 6, 2025 | 62.4M | +7.9% | SEC |
| Jul 31, 2025 | 62.4M | +8.4% | SEC |
| May 1, 2025 | 58.8M | +2.1% | SEC |
| Mar 13, 2025 | 58.6M | +2.0% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.